HCA Healthcare Files 8-K on Financials and Operations
Ticker: HCA · Form: 8-K · Filed: Jan 24, 2025 · CIK: 860730
Sentiment: neutral
Topics: financial-reporting, operations, sec-filing
Related Tickers: HCA
TL;DR
HCA Healthcare dropped an 8-K detailing financials and operations as of Jan 24, 2025.
AI Summary
HCA Healthcare, Inc. filed an 8-K on January 24, 2025, reporting on its results of operations and financial condition. The filing also included disclosures related to Regulation FD and other events, along with financial statements and exhibits. The company, formerly known as HCA Holdings, Inc., is headquartered in Nashville, Tennessee.
Why It Matters
This filing provides investors with crucial updates on HCA Healthcare's financial performance and operational status, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine 8-K filing providing standard financial and operational updates, not indicating any immediate or significant new risks.
Key Players & Entities
- HCA Healthcare, Inc. (company) — Registrant
- HCA Holdings, Inc. (company) — Former company name
- Nashville, Tennessee (location) — Headquarters
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on HCA Healthcare, Inc.'s results of operations and financial condition, as well as to provide disclosures related to Regulation FD and other events.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on January 24, 2025.
What is HCA Healthcare, Inc.'s principal executive address?
HCA Healthcare, Inc.'s principal executive address is One Park Plaza, Nashville, Tennessee, 37203.
What were HCA Healthcare's former company names?
HCA Healthcare's former company names include HCA Holdings, Inc., HCA INC/TN, and HCA THE HEALTHCARE CO.
Under which section of the Securities Exchange Act is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 580 words · 2 min read · ~2 pages · Grade level 9.8 · Accepted 2025-01-24 07:40:45
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value per share HCA New York St
- $10 billion — onal share repurchase program for up to $10 billion of the Company's outstanding common sto
- $0.72 — d declared a quarterly cash dividend of $0.72 per share of the Company's common stock
Filing Documents
- hca-20250124.htm (8-K) — 44KB
- hca-ex99_1.htm (EX-99.1) — 1204KB
- img60930783_0.jpg (GRAPHIC) — 99KB
- 0000950170-25-008608.txt ( ) — 1540KB
- hca-20250124.xsd (EX-101.SCH) — 24KB
- hca-20250124_htm.xml (XML) — 5KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On January 24, 2025, HCA Healthcare, Inc. (the "Company") issued a press release announcing, among other matters, its results of operations for the fourth quarter and year ended December 31, 2024, the text of which is set forth as Exhibit 99.1 .
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On January 24, 2025, the Company issued a press release announcing, among other matters, its results of operations for the fourth quarter and year ended December 31, 2024, the text of which is set forth as Exhibit 99.1 .
01. Other Events
Item 8.01. Other Events. On January 24, 2025, the Company announced that its Board of Directors had authorized an additional share repurchase program for up to $10 billion of the Company's outstanding common stock. Repurchases will be made in accordance with applicable securities laws from time to time in the open market, through privately negotiated transactions, or otherwise. On January 24, 2025, the Company announced that its Board of Directors had declared a quarterly cash dividend of $0.72 per share of the Company's common stock. The dividend will be paid on March 31, 2025 to stockholders of record at the close of business on March 17, 2025.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits: Exhibit 99.1 Press Release, dated January 24, 2025 Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HCA HEALTHCARE, INC. Date: January 24, 2025 By: /s/ Michael A. Marks Michael A. Marks Executive Vice President and Chief Financial Officer